Cytek Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	836	1,236	1,377	2,182
Market Cap Growth	-	-10.21%	-36.91%	-
Enterprise Value	585	985	1,047	1,818
PE Ratio	-101.76	-101.76	534.49	-
PS Ratio	4.33	6.41	8.39	17.06
PB Ratio	2.13	3.15	3.24	5.39
P/FCF Ratio	1841.74	2722.93	-62.30	8204.54
P/OCF Ratio	158.33	234.09	-112.57	471.36
EV/Sales Ratio	3.03	5.10	6.39	14.21
EV/EBITDA Ratio	-223.37	-223.37	109.29	204.36
EV/EBIT Ratio	-72.19	-72.19	266.85	237.53
EV/FCF Ratio	1287.53	2168.71	-47.40	6833.79
Debt / Equity Ratio	0.03	0.03	0.03	-
Debt / EBITDA Ratio	-2.52	-2.52	1.52	-
Debt / FCF Ratio	24.51	24.51	-0.66	-
Quick Ratio	5.67	5.67	8.01	11.89
Current Ratio	6.97	6.97	9.26	13.01
Asset Turnover	0.37	0.37	0.33	0.37
Interest Coverage	-6.59	-6.59	1.53	4.40
Return on Equity (ROE)	-2.90%	-2.90%	0.60%	0.00%
Return on Assets (ROA)	-2.40%	-2.40%	0.50%	0.00%
Return on Capital (ROIC)	-6.89%	-6.89%	-0.78%	1.15%
Earnings Yield	-1.45%	-0.98%	0.19%	-
FCF Yield	0.05%	0.04%	-1.61%	0.01%
Buyback Yield / Dilution	2.37%	2.37%	-69.93%	-150.13%
Total Shareholder Return	2.37%	2.37%	-69.93%	-150.13%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).